Sherene Loi, Prof
Peter MacCallum Cancer Centre, Australia
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Sherene Loi, Prof as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:59 UTC. Open this list on ClinicalTrials.gov
- N/ANCT07465172 · GDF-15 and Its Relationship With Treatment-related ADverse Events in Breast CancerBreast Cancer Trials, Australia and New Zealand · not yet recruiting · Breast Cancer · study chair
- Ph2NCT04789096 · Tucatinib Together With Pembrolizumab and TrastuzumabBreast Cancer Trials, Australia and New Zealand · terminated · Breast Cancer, HER2-positive Breast Cancer · study chair
- Ph2NCT03464942 · Stereotactic Radiation and Immunotherapy in Patients With Advanced Triple Negative Breast CancerPeter MacCallum Cancer Centre, Australia · completed · Breast Cancer · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:59 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in breast cancer.